Three narrative about the universe of opioids collide: a drug seller arrange a multi-cartel Sublimaze smuggle operation between Canada and the United States government, an designer recover from an OxyContin dependence path down the truth behind her son’s engagement with narcotic, and a university prof battle unexpected disclosure about his research employer, a drug company with deep authorities influence bring a new “non-addictive” analgesic to marketplace.